Tools

LEADER 03242cam a2200613 i 4500

001 on1398506232;

003 OCoLC;

005 20240202143420.0;

006 m o d f ;

007 cr |||||||||||;

008 230921m20239999dcu ob f000 0 eng c;

024 8 a| 52-570q| (GPO jacket number);

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1016-C (online);

086 0 a| Y 4.OV 2:118-36;

086 0 a| Y 4.OV 2:118-66;

088 a| Serial no. 118-36 (United States. Congress. House. Committee on Oversight and Accountability);

088 a| Serial no. 118-66 (United States. Congress. House. Committee on Oversight and Accountability);

245 14 a| The role of pharmacy benefit managers in prescription drug markets :b| hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session.;

246 1 i| Part II has title:a| The role of pharmacy benefit managers in prescription drug markets.n| Part II :b| not what the doctor ordered;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2023.;

300 a| 1 online resource (volumes);

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| "May 23, 2023"--Pt. I.;

500 a| "September 19, 2023"--Pt. II;

505 0 a| Pt. 1. Self-interest or healthcare? -- Pt. II. Not what the doctor ordered.;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| "Serial no. 118-36"--Pt. 1.;

500 a| "Serial no. 118-66"--Pt. II.;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| "Hearing witnesses: Dr. Miriam J. Atkins, Oncologist, Augusta Oncology Associate; Mr. Greg Baker, CEO, AffirmedRx, PBC; Mr. Kevin J. Duane, Owner, Panama Pharmacy, Jacksonville, Florida; Mr. Frederick Isasi (Minority Witness), Executive Director, Families USA"--Pt. I.;

518 a| "Date of hearing: 2023-05-23"--Pt. I.;

588 a| Description based on online resource; title from PDF title page, pt. 1 (GovInfo, viewed Sep. 21, 2023).;

650 0 a| Prescription pricingz| United States.=| ^A5242;

650 0 a| Pharmaceutical industryz| United States.=| ^A638;

650 0 a| Drugsx| Pricesz| United States.=| ^A30023;

650 0 a| Drugsz| United Statesx| Cost control.=| ^A640;

650 7 a| Congress.2| cgpa;

650 7 a| Health.2| cgpa;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Print version:a| United States. Congress. House. Committee on Oversight and Accountability.t| Role of pharmacy benefit managers in prescription drug marketsw| (OCoLC)1398501889;

856 40 u| https://purl.fdlp.gov/GPO/gpo2182877| 0;

922 a| BIBCONEW;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6274408;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6274408-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 10/24/2023x| EDOCUMENTz| JERESOURCE;

The role of pharmacy benefit managers in prescription drug markets : hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2023.
Description	1 online resource (volumes)
Supplemental Content	https://purl.fdlp.gov/GPO/gpo218287
Subjects	Prescription pricing--United States. Pharmaceutical industry--United States. Drugs--Prices. --United States. Drugs--United States. --Cost control.

Variant title	Part II has title: The role of pharmacy benefit managers in prescription drug markets. Part II : not what the doctor ordered
Contents	Pt. 1. Self-interest or healthcare? -- Pt. II. Not what the doctor ordered.
General note	"May 23, 2023"--Pt. I.
General note	"September 19, 2023"--Pt. II
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	"Serial no. 118-36"--Pt. 1.
General note	"Serial no. 118-66"--Pt. II.
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	"Hearing witnesses: Dr. Miriam J. Atkins, Oncologist, Augusta Oncology Associate; Mr. Greg Baker, CEO, AffirmedRx, PBC; Mr. Kevin J. Duane, Owner, Panama Pharmacy, Jacksonville, Florida; Mr. Frederick Isasi (Minority Witness), Executive Director, Families USA"--Pt. I.
Date/time/place of a event note	"Date of hearing: 2023-05-23"--Pt. I.
Source of description	Description based on online resource; title from PDF title page, pt. 1 (GovInfo, viewed Sep. 21, 2023).
Issued in other form	Print version: United States. Congress. House. Committee on Oversight and Accountability. Role of pharmacy benefit managers in prescription drug markets
Genre/form	Legislative hearings.
Standard identifier#	52-570 (GPO jacket number)
Technical rpt number	Serial no. 118-36 (United States. Congress. House. Committee on Oversight and Accountability)
Technical rpt number	Serial no. 118-66 (United States. Congress. House. Committee on Oversight and Accountability)
GPO item number	1016-C (online)
Govt. docs number	Y 4.OV 2:118-36
Govt. docs number	Y 4.OV 2:118-66

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

The role of pharmacy benefit managers in prescription drug markets : hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session.

Click here for more information about this title

Availability